相关实验视频
Updated: May 27, 2025
09:16
Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
17.5K
在糖尿病病患者中使用达帕格利弗洛辛,患者的过状态不同
Yang Yang1, Manna Li2, Honghong Zou2
1Department of Nephrology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, PR China; Jiangxi Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, PR China.
概括
在糖尿病病 (DKD) 患者治疗达帕格利弗洛辛时,根据过状态和血压,患者表现出不同的效果. 不过过和降低缩血压 (SBP) 的结果更好,分泌可能解释功能变化.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病病 (DKD) 的进展受膜过率 (GFR) 和静脉血压 (SBP) 的影响.
- 关于达帕格利弗洛辛在不同GFR和SBP水平的DKD患者的差异性作用的研究有限.
- 了解这些变化对于优化DKD管理至关重要.
研究的目的:
- 调查达帕格利弗洛辛对估计GFR (eGFR) 和蛋白尿症在DKD患者的影响.
- 分析基于先前存在的过状态和SBP水平的治疗变化.
- 探索达帕格利弗洛辛对功能影响背后的潜在机制.
主要方法:
- 一项横截面研究确定了DKD的过率值.
- 259名DKD患者的eGFR>70mL/min/1.73m2和专与肌素比率 (ACR) 30-200 mg/g接受了达帕格利弗洛辛.
- 患者按过状态和SBP (>120 mmHg vs. ≤120 mmHg) 分层;治疗前和后测量了eGFR和ACR.
主要成果:
- 2周后EGFR的平均变化在SBP>120 mmHg组的过中比SBP ≤120 mmHg组的非过中更大 (P=0.048).
- 在12周的ACR平均降低在不过的SBP ≤120 mmHg组中更大 (P=0.042).
- 部分分泌 (FENa) 最初增加 (P<0.001),然后恢复 (P=0.305),其他电解质没有显著变化.
结论:
- 没有过和SBP≤120mmHg的DKD患者经历了较少的eGFR下降和较大的ACR降低.
- 治疗后FENa的短暂增加可能会导致观察到的eGFR变异.
- 达帕格利弗洛辛在DKD中的疗效是由基线过和血压状态调节的.
相关概念视频
01:02Renal Drug Excretion: Glomerular Filtration
124
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
124
01:23Dipeptidyl Peptidase 4 Inhibitors
164
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
164
01:11Renal Failure: Dose Adjustments
60
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
60
01:17Factors Affecting Renal Clearance: Renal Impairment
48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48
01:20Renal Corpuscle
1.6K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.6K
01:27Dialysis
252
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
252